These fundamental differences in lipoprotein profiles between humans and mice also suggest that the choice of animal model should be carefully considered in future studies aiming to test PCSK9 inhibitors in vivo as a therapy for sepsis. The gene discussed is PCSK9; the disease is Sepsis.